We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
-16.99%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$22.6B
AUM Growth
-$5.2B
(-19%)
Cap. Flow
+$807M
Cap. Flow
% of AUM
3.57%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
2,461
New
137
Increased
1,389
Reduced
800
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$72.4M |
| 2 |
Microsoft
MSFT
|
+$42.4M |
| 3 |
CERN
Cerner Corp
CERN
|
+$38.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$29.6M |
| 5 |
Gilead Sciences
GILD
|
+$24.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$50M |
| 2 |
Chevron
CVX
|
+$43.5M |
| 3 |
Wells Fargo
WFC
|
+$33.6M |
| 4 |
Phillips 66
PSX
|
+$31.6M |
| 5 |
Walt Disney
DIS
|
+$31.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.63% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.12% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANH
2276
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $53K | ﹤0.01% |
46,686
-87,484
| -65% | -$266K |
|
|
ADAP
2277
DELISTED
Adaptimmune Therapeutics
ADAP
| $51K | ﹤0.01% |
+18,598
| New | +$61.7K |
|
|
RUBY
2278
DELISTED
Rubius Therapeutics, Inc
RUBY
| $51K | ﹤0.01% |
+11,417
| New | +$84.8K |
|
2279
Rigel Pharmaceuticals
RIGL
$723M
| $50K | ﹤0.01% |
3,191
-427
| -12% | -$9.09K |
|
2280
TherapeuticsMD
TXMD
$23.8M
| $47K | ﹤0.01% |
892
-3
| -0.3% | -$297 |
|
2281
Nabors Industries
NBR
$1.17B
| $46K | ﹤0.01% |
2,354
-3,648
| -61% | -$334K |
|
|
GNMK
2282
DELISTED
GenMark Diagnostics, Inc
GNMK
| $42K | ﹤0.01% |
+10,174
| New | +$47.7K |
|
2283
Modine Manufacturing
MOD
$9.46B
| $40K | ﹤0.01% |
12,165
-16,984
| -58% | -$113K |
|
|
VRAY
2284
DELISTED
ViewRay, Inc.
VRAY
| $40K | ﹤0.01% |
+15,935
| New | +$45.1K |
|
|
JCP
2285
DELISTED
J.C. Penney Company, Inc.
JCP
| $39K | ﹤0.01% |
108,754
+24,230
| +29% | +$17.1K |
|
2286
Goldgroup Mining Inc.
GORO
$155M
| $38K | ﹤0.01% |
13,887
-289
| -2% | -$1.3K |
|
|
CHS
2287
DELISTED
Chicos FAS, Inc.
CHS
| $37K | ﹤0.01% |
28,752
-70,298
| -71% | -$242K |
|
2288
BioCryst Pharmaceuticals
BCRX
$2.42B
| $36K | ﹤0.01% |
17,872
+13
| +0.1% | +$36 |
|
2289
Chord Energy
CHRD
$7.68B
| $35K | ﹤0.01% |
100,169
-203,605
| -67% | -$373K |
|
|
BKCC
2290
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $34K | ﹤0.01% |
15,527
-8,194
| -35% | -$35.4K |
|
|
QEP
2291
DELISTED
QEP RESOURCES, INC.
QEP
| $33K | ﹤0.01% |
98,070
-127,096
| -56% | -$306K |
|
2292
McEwen Inc
MUX
$1B
| $32K | ﹤0.01% |
4,884
-7,852
| -62% | -$81K |
|
|
SPPI
2293
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $31K | ﹤0.01% |
13,490
-2,182
| -14% | -$5.97K |
|
|
RRD
2294
DELISTED
RR Donnelley & Sons Co.
RRD
| $31K | ﹤0.01% |
32,348
+7,529
| +30% | +$18.2K |
|
2295
Garrett Motion
GTX
$5.37B
| $30K | ﹤0.01% |
10,403
-16,551
| -61% | -$120K |
|
2296
Abeona Therapeutics
ABEO
$355M
| $29K | ﹤0.01% |
552
-153
| -22% | -$10.2K |
|
|
CLSD
2297
DELISTED
Clearside Biomedical
CLSD
| $27K | ﹤0.01% |
1,040
| – | – |
|
2298
Groupon
GRPN
$1.03B
| $27K | ﹤0.01% |
1,391
-311
| -18% | -$12.3K |
|
2299
Standard BioTools
LAB
$342M
| $27K | ﹤0.01% |
+10,579
| New | +$34.8K |
|
|
NPKI
2300
NPK International
NPKI
$1.02B
| $27K | ﹤0.01% |
30,042
-1,354
| -4% | -$5.07K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q1 2020 Portfolio in Review
As of Q1 2020, Aperio Group held 2,461 positions worth $22.6B, down 19% from $27.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aperio Group deployed $807M of net new capital in Q1 2020, opening 137 new positions and adding to 1,389 existing holdings. Its largest new stake was Ingersoll Rand: 170,073 shares worth $4.22M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was PepsiCo, an estimated $50M trimmed.
- Aperio Group's largest Q1 2020 buy was Ingersoll Rand: 170,073 shares worth $4.22M.
- Aperio Group added most to Amazon in Q1 2020, an estimated $72.4M increase.
- Aperio Group's biggest Q1 2020 reduction was PepsiCo, cutting an estimated $50M.
- Aperio Group fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $9.6M.
- Aperio Group's ten largest holdings make up 20% of its $22.6B portfolio in Q1 2020.
- Aperio Group opened 137 new positions and closed 128 in Q1 2020.
- Aperio Group's portfolio value fell 19% quarter-over-quarter to $22.6B.
Based on Aperio Group's 13F filing for Q1 2020, filed 5 May 2020.